NOVELION THERAPEUTICS

novelion-therapeutics-logo

Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The Company's portfolio of products include MYALEPT and JUXTAPID. The Company is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.

#SimilarOrganizations #People #Financial #Website #More

NOVELION THERAPEUTICS

Industry:
Biopharma Biotechnology Therapeutics

Founded:
1981-01-01

Address:
Vancouver, British Columbia, Canada

Country:
Canada

Website Url:
http://www.novelion.com

Total Employee:
251+

Status:
Active

Contact:
604.707.7000

Email Addresses:
[email protected]

Total Funding:
72 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail IPv6 GoDaddy DNS Amazon Virginia Region OVH Mimecast Akamai Hosted


Similar Organizations

avalo-therapeutics-logo

Avalo Therapeutics

Avalo Therapeutics is a clinical-stage biopharmaceutical company.


Current Advisors List

mark-corrigan_image

Mark Corrigan Board Member @ Novelion Therapeutics
Board_member
2017-04-01

Current Employees Featured

not_available_image

Robert L. Butchofsky
Robert L. Butchofsky President & CEO @ Novelion Therapeutics
President & CEO

not_available_image

Cameron R. Nelson
Cameron R. Nelson CFO @ Novelion Therapeutics
CFO

Founder


julia-levy_image

Julia Levy

Stock Details


Company's stock symbol is NASDAQ:NVLN

Acquisitions List

Date Company Article Price
2016-06-15 Aegerion Pharmaceuticals Aegerion Pharmaceuticals acquired by Novelion Therapeutics N/A

Investors List

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - Novelion Therapeutics

Investments List

Date Company Article Money raised
2015-06-08 Aralez Pharmaceuticals Novelion Therapeutics investment in Post-IPO Equity - Aralez Pharmaceuticals 350 M USD

Official Site Inspections

http://www.novelion.com

  • Host name: ec2-107-22-175-16.compute-1.amazonaws.com
  • IP address: 107.22.175.16
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Novelion Therapeutics" on Search Engine